¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ratio of accommodative convergence to accommodation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • convergence amplitude
    ´«¸ðÀ½´É·Â
  • convergence excess
    ´«¸ðÀ½°ú´Ù
  • convergence insufficiency
    ´«¸ðÀ½ºÎÀü, ÆøÁÖºÎÀü
  • convergence insufficiency exotropia
    ´«¸ðÀ½ºÎÁ·¿Ü»ç½Ã, ÆøÁÖºÎÁ·¿Ü»ç½Ã
  • convergence nystagmus
    ´«¸ðÀ½´«¶³¸², ÆøÁÖ¾ÈÁø
  • convergence palsy
    ´«¸ðÀ½¸¶ºñ, ÆøÁÖ¸¶ºñ
  • convergence reflex
    ´«¸ðÀ½¹Ý»ç
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³, ´«¸ðÀ½Åõ»ç¼³
  • convergence-retraction nystagmus
    ´«¸ðÀ½ÈÄÅð´«¶³¸², ÆøÁÖÈÄÅð¾ÈÁø
  • fusional convergence
    À¶ÇÕ´«¸ðÀ½
  • near convergence
    ±ÙÁ¢´«¸ðÀ½
  • negative convergence
    À½¼º´«¸ðÀ½
  • positive convergence
    ¾ç¼º´«¸ðÀ½
  • prism convergence
    ÇÁ¸®Áò´«¸ðÀ½
  • proximal convergence
    ±ÙÁ¢´«¸ðÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • convergence
    ´«¸ðÀ½
  • convergence excess
    ´«¸ðÀ½°ú´Ù
  • convergence insufficiency
    ´«¸ðÀ½ºÎÁ·, ÆøÁÖºÎÁ·
  • convergence nystagmus
    ´«¸ðÀ½´«¶³¸², ÆøÁÖ¾ÈÁø
  • convergence palsy
    ´«¸ðÀ½¸¶ºñ
  • convergence reflex
    ´«¸ðÀ½¹Ý»ç
  • convergence spasm
    ´«¸ðÀ½¿¬Ãà
  • convergence insufficiency exotropia
    ´«¸ðÀ½ºÎÁ·¿Ü»ç½Ã
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³
  • convergence-retraction nystagmus
    ´«¸ðÀ½ÈÄÅð´«¶³¸², ÆøÁÖÈÄÅð¾ÈÁø
  • fusional convergence
    À¶ÇÕ´«¸ðÀ½
  • near convergence
    ±ÙÁ¢´«¸ðÀ½
  • negative convergence
    À½¼º´«¸ðÀ½
  • positive convergence
    ¾ç¼º´«¸ðÀ½
  • prism convergence
    ÇÁ¸®Áò´«¸ðÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • accommodative palsy
    Á¶Àý¸¶ºñ
  • accommodative pupillary reflex
    Á¶Àý¼ºµ¿°ø¹Ý»ç
  • accommodative reflex
    Á¶Àý¹Ý»ç
  • accommodative spasm
    Á¶Àý¿¬Ãà
  • accommodative strabismus
    Á¶Àý(¼º)»ç½Ã
  • accommodative target
    Á¶ÀýÀ¯¹ß½ÃÇ¥
  • amplitude of convergence
    ´«¸ðÀ½´É·Â, ÆøÁÖ·Â(ÜßñÍøë)
  • fusional convergence
    À¶ÇÕ¼º´«¸ðÀ½, À¶ÇÕ¼ºÆøÁÖ
  • hilum convergence sign
    Æó¹®¼ö·Å¡ÈÄ.
  • hilum convergence sign
    Æó¹® ¼ö·Å ¡ÈÄ
  • insufficiency of convergence
    ´«¸ðÀ½ºÎÁ·, ÆøÁÖºÎÁ·
  • point of basal convergence
    ±âÃÊÆøÁÖÁ¡(Ðñõ¨ÜßñÍïÇ).
  • point of convergence
    ÆøÁÖÁ¡(ÜßñÍïÇ).
  • positive convergence
    ¾ç¼º´«¸ðÀ½, ¾ç¼ºÆøÁÖ(¡­ÜßñÍ).
  • principle of convergence
    ÆøÁÖ¿øÄ¢(ÜßñÍ ê«öÎ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • paralysis of accommodation
    Á¶Àý¸¶ºñ
  • paresis of accommodation
    Á¶Àý(ðàï½)ºÎÀü¸¶ºñ
  • punctum proximum of accommodation
    Á¶Àý±ÙÁ¡
  • range of accommodation
    Á¶Àý¹üÀ§(ðàï½çÐæ´).
  • reflex accommodation
    ¹Ý»ç¼º Á¶Àý(ÚãÞÒàõðàï½).
  • region of accommodation
    Á¶Àý¹üÀ§
  • relative accommodation
    »ó´ëÁ¶Àý(ÝïÎòðàï½).
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • spasm of accommodation
    Á¶Àý¿¬Ãà
  • subnormal accommodation
    ¾ÆÁ¤»óÁ¶Àý, ÁØÁ¤»óÁ¶Àý(Ì¡ËøË×Ì¡Ëø).
  • weakness of accommodation
    Á¶Àý¾àÈ­
  • amplitude of convergence
    ´«¸ðÀ½´É·Â, ÆøÁÖ·Â(ÜßñÍøë)
  • convergence
    ¼ö·Å(â¥Ö°), ÁýÇÕ(ó¢ùê).
  • convergence
    ¸ðÀ̱â
  • convergence
    ´«¸ðÀ½, ÆøÁÖ(ÜßñÍ), ¼ö·Å(â¥Ö°),
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • P:O ratio
    P/O ºñ
  • protein efficiency ratio
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ(üù×ËÝï)
  • protein efficiency ratio method
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ¹ý(üù×ËÝïÛö)
  • signal-to-noise ratio
    ½ÅÈ£/ÀâÀ½ºñ(ãáûÜ/íÚëåÝï)
  • viscosity ratio
    Á¡µµÀ²(ïÄÓøëÒ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
Accom. Accommodation; ¼øÀÀ
L & A Light & Accommodation; ±¤¼±¹× Á¶Àý
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
acc acceleration, accelerator; accident; accommodation
acc insuff accommodation insufficiency
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
C/N Contrast-to-noise ratio
CER Cost-effectiveness ratio
D/P Dialysate-to-plasma ratio
DAR Differential absorption ratio
ER Enhancement Ratio
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • body-weight ratio
    üÁß ½ÅÀå ºñ
  • cardiothoracic ratio
    ½ÉÈäºñ, ½ÉÈä°û ºñ, ½ÉÈä °è¼ö
  • cell color ratio
    Ç÷±¸»ö¼Òºñ, ÀûÇ÷±¸ »ö¼Òºñ
  • child woman ratio
    ¸ð¾Æ ºñÀ²
  • crown-root ratio
    Ä¡°ü´ë Ä¡±Ùºñ
  • curative ratio
    Ä¡À¯À²
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • effective ratio
    À¯È¿À²
    ¾î´À ÇѰè±îÁö´Â ¾àÁ¦ ¿ë·®°ú À¯È¿À²Àº ºñ·ÊÇÑ´Ù. ÇѰè À̻󿡼­´Â ºÎÀÛ¿ëÀÌ ³ªÅ¸³­´Ù.
  • expansion ratio
    ÆØÃ¢ºñ
  • innervation ratio
    ½Å°æ Áö¹è ºñ
  • magnetization transfer ratio
    ÀÚÈ­ Àü´Þ ºñÀ²
  • mercuryalloy ratio
    ¼öÀº Çձݺñ
  • monocyte lymphocyte ratio
    ´Ü±¸ ¸²ÇÁ±¸ºñ
  • optimal ratio
    ÃÖÀûºñ
  • optimum ratio
    ÃÖÀûºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
positive convergence Inward deviation of the visual axes even when convergence is at rest, as in cases of convergent squint.
(05 Mar 2000)
near point of convergence The point to which the visual lines are directed when convergence is at its maximum.
(05 Mar 2000)
negative convergence The slight divergence of the visual axes when convergence is at rest, as when observing the far point or during sleep.
(05 Mar 2000)
far point of convergence The point to which the visual lines are directed when convergence is at rest.
(05 Mar 2000)
unit of convergence See: meter angle.
(05 Mar 2000)
unit of ocular convergence The amount of convergence required to view binocularly an object 1 meter distant and exerting 1 diopter of accommodation.
Synonym: unit of ocular convergence.
(05 Mar 2000)
absolute terminal innervation ratio The number of motor endplates divided by the number of terminal axons related to them.
(05 Mar 2000)
A/G ratio <abbreviation> Albumin-globulin ratio.
(05 Mar 2000)
albumin-globulin ratio The ratio of albumin to globulin in the serum or in the urine in kidney disease; the normal ratio in the serum is approximately 1.55.
(05 Mar 2000)
ALT:AST ratio The ratio of serum alanine aminotransferase to serum aspartate aminotransferase; elevated serum levels of both enzymes characterise hepatic disease; when both levels are abnormally elevated and the ALT:AST ratio is greater than 1.0, severe hepatic necrosis or alcoholic hepatic disease is likely; when the ratio is less than 1.0, an acute non-alcoholic hepatic condition is favoured.
(05 Mar 2000)
amylase-creatinine clearance ratio A test for the diagnosis of acute pancreatitis; it is determined by measuring amylase and creatinine in serum and urine in apparently healthy individuals the renal clearance of amylase is less than 5% that of creatinine; in acute pancreatitis the ratio is said to be greater than 0.05 or 5%.
(05 Mar 2000)
aspect ratio <radiobiology> In toroidal geometry, the ratio of the major diameter (total width of the torus) to the minor diameter (width of a slice taken through one side of the ring). In inertial-confinement fusion, aspect ratio refers to the ratio of a fuel pellet's radius to its wall thickness.
(09 Oct 1997)
at/gc ratio <molecular biology> The ratio of adenine-thymine base pairs to guanine-cytosine base pairs on a DNA molecule.
(09 Oct 1997)
basic reproductive rate, ratio <epidemiology> See Reproductive Ratio.
(05 Dec 1998)
body-weight ratio Body weight (in grams) divided by stature (in centimeters).
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á